CMPX R&D Expenses
Compass Therapeutics · R&D Expenses
CMPX R&D Expenses
Latest reported$59.45Mperiod ending
CMPX TTM R&D Expenses ($21.91M → $59.45M)
TTM R&D Expenses
High-resolution chart · PNG
CMPX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 59,451,000 | |
| 56,290,000 | |
| 55,969,000 | |
| 55,333,000 | |
| 51,119,000 | |
| 45,878,000 | |
| 42,346,000 | |
| 41,734,000 | |
| 41,953,000 | |
| 41,002,000 | |
| 38,118,000 | |
| 35,620,000 | |
| 36,580,000 | |
| 32,219,000 | |
| 29,996,000 | |
| 29,642,000 | |
| 23,005,000 | |
| 20,048,000 | |
| 20,337,000 | |
| 15,169,000 | |
| 15,685,000 | |
| 15,765,000 | |
| 14,632,000 | |
| 13,529,000 | |
| 15,838,000 | |
| 18,242,000 | |
| 21,914,000 | |
| 18,611,000 |